Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin

References

• http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020712s030lbl.pdf FDA label carbatrol
   Google Scholar
• Moneghini M, Voinovich D, Perissutti B, Princivalle F. Action of carriers on carbamazepine dissolution. Pharm Dev Technol 2002;7:289–296.
   PubMed Web of Science ®Google Scholar
• Douroumis D, Fahr A. Stable carbamazepine colloidal systems using the cosolvent technique. Eur J Pharm Sci. 2007;30:367–374.
   PubMed Web of Science ®Google Scholar
• Rustichelli C, Gamberini G, Ferioli V, Gamberini M, Ficarra R, Tommasini S. Solid-state study of polymorphic drugs: Carbamazepine. J Pharm Biomed Anal 2000;23:41–54.
   PubMed Web of Science ®Google Scholar
• Grzesiak AL, Lang M, Kim K, Matzger AJ. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of the form 1. J Pharm Sci 2003;92:2260–2271.
   PubMed Web of Science ®Google Scholar
• Behme RJ, Brooke D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J Pharm Sci 1991;80:986–990.
   PubMed Web of Science ®Google Scholar
• Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette SL, Vetter A, Guzmán H, Remenar JF, Zhang Z, Tawa MD, Haley S, Zaworotko MJ, Almarsson O. Performance comparison of a cocrystal of carbamazepine with marketed product. Eur J Pharm Biopharm 2007;67:112–119.
   PubMed Web of Science ®Google Scholar
• Laine E, Tuominen V, Ilvessalo P, Kahela P. Formation of dihydrate from carbamazepine anhydrate in aqueous conditions. Int J Pharm 1984;20:307–314.
   Web of Science ®Google Scholar
• Young WW, Suryanarayanan R. Kinetics of transition of anhydrous carbamazepine to carbamazepine dihydrate in aqueous suspensions. J Pharm Sci 1991;80:496–500.
   PubMed Web of Science ®Google Scholar
• Luhtala S. Effect of sodium lauryl sulphate and polysorbate 80 on crystal growth and aqueous solubility of carbamazepine. Acta Pharm Nord 1992;4:85–90.
   Google Scholar
• Trask AV, Motherwell WDS, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm 2006;320:114–123.
   PubMed Web of Science ®Google Scholar
• Karki S, Friščić T, Fábián L, Laity PR, Day GM, Jones W. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv Mat 2009;21:3905–3909.
   Web of Science ®Google Scholar
• McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O’Donnell E, Park A. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharma Res 2006;23:1888–1897.
   Google Scholar
• Variankaval N, Wenslow R, Murry J, Hartman R, Helmy R, Kwong E, Clas SD, Dalton C, Santos I. Preparation and solid-state characterization of nonstoichiometric co-crystals of a phosphodiesterase-IV inhibitor and L-tartaric acid. Cryst Growth Des 2006;6:690–700.
   Web of Science ®Google Scholar
• Good DJ, Rodríguez-Hornedo N. Solubility advantage of pharmaceuticalcocrystals. Crystal Growth Des 2009;9:2252–2264.
   Web of Science ®Google Scholar
• Rodríguez-Hornedo N, Nehm SJ, Seefeldt KF, Paga’n-Torres Y, Falkiewicz CJ. Reaction crystallization of pharmaceutical molecular complexes. Mol Pharm 2006;3:362–367.
   PubMed Web of Science ®Google Scholar
• http://www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfm
   Google Scholar
• Padrela L, Rodrigues MA, Velaga SP, Matos HA, de Azevedo EG. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur J Pharm Sci 2009;38:9–17.
   PubMed Web of Science ®Google Scholar
• Shiraki K, Takata N, Takano R, Hayashi Y, Terada K. Dissolution improvement and the mechanism of the improvement from cocrystallization of poorly water-soluble compounds. Pharm Res 2008;25:2581–2592.
   PubMed Web of Science ®Google Scholar
• Takata N, Takano R, Uekusa H, Hayashi Y, Terada K. A spironolactone-saccharin 1:1 cocrystal hemihydrate. Cryst Growth Des 2010;10: 2116–2122.
   Web of Science ®Google Scholar
• Velaga SP, Basavoju S Boströ MD. Norfloxacin saccharinate-saccharin dihydrate cocrystal - A new pharmaceutical cocrystal with an organic counter ion. J Mol Struct 2008;889:150–153.
   Web of Science ®Google Scholar
• Aitipamula S, Chow PS, Tan RBH. Dimorphs of a 1:1 cocrystal of ethenzamide and saccharin: solid-state grinding methods result in metastable polymorph. Cryst Eng Comm 2009;11:889–895.
   Google Scholar
• Jayasankar A, Good DJ, Rodríguez-Hornedo N. Mechanisms by which moisture generates cocrystals. Mol Pharm 2007;4:360–372.
   PubMedGoogle Scholar
• Zakeri-Milani P, Barzegar-Jalali M, Azimi M, Valizadeh H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. Eur J Pharm Biopharm 2009;73:102–106.
   PubMed Web of Science ®Google Scholar
• Bethune SJ, Huang N, Jayasankar A, Rodrıguez-Hornedo N. Understanding and predicting the effect of cocrystal components and pH on cocrystal solubility. Cryst Growth Des 2009;9:3976–3988.
   Web of Science ®Google Scholar
• International conference of harmonization-validation of analytical procedures Q2(R1), 2005.
   Google Scholar
• Fell JT, Newton JM. The tensile strength of lactose tablets. J Pharm Pharmacol 1968;20:657–758.
   PubMed Web of Science ®Google Scholar
• Heckel RW. An analysis of powder compaction phenomena. Trans AIME 1996;221:1001–1008.
   Google Scholar
• Paronen P, Iilla J. 1996. Porosity-pressure functions. In: Alderborn G, Nyström C, eds, Pharmaceutical Powder Compaction Technology. New York: Marcel Dekker Inc, 1996:55–75.
   Google Scholar
• Murphy D, Rodríguez-Cintro’n F, Langevin B, Kelly RC, Rodríguez-Hornedo N. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm 2002;246:121–134.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Bhatt PM, Ravindra NV, Desiraju GR. Saccharins salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities. Cryst Growth Des 2005;5:2299–2309.
   Web of Science ®Google Scholar
• Nair R, Nyamweya N, Gonen S, Martinez-Miranda LJ, Hoag SW. Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. Int J Pharm 2001;225:83–96.
   PubMed Web of Science ®Google Scholar
• Hase Y. 1978. The infrared and Raman spectra of phthalimide, N-D-phthalimide and potassium phthalimide. J Mol Struct 1978;48:33–42
   Web of Science ®Google Scholar
• Jovanovski G, Tanceva S, Soptrajanov B. The SO2 stretching vibrations in some metal saccharinates: spectra-structure correlations. Spectrosc Lett 1995;28:1095–1109.
   Web of Science ®Google Scholar
• Jayasankar A, Somwangthanaroj A, Shao ZJ, Rodríguez-Hornedo N. Cocrystal formation during cogrinding and storage is mediated by amorphous phase. Pharm Res 2006;23:2381–2392.
   PubMed Web of Science ®Google Scholar
• Fleischman SG, Kuduva SS, McMahon JA, Moulton B, Walsh RDB, Rodríguez-Hornedo N, Zaworotko MJ. Crystal engineering of the composition of pharmaceutical phases: multiple component crystalline solids involving carbamazepine. Cryst Growth Des 2003;3:909–919
   Web of Science ®Google Scholar
• Porter WW, Elie SC, Matzger AJ. Polymorphism in carbamazepine cocrystals. Cryst Growth Des 2008;8:14–16.
   PubMed Web of Science ®Google Scholar
• Saravanan M, Nataraj KS, Ganesh KS. The effect of tablet formulation and hardness on in vitro release of cephalexin from Eudragit L100 based extended release tablets. Bio Pharm Bull 2002;25:541–545.
   PubMed Web of Science ®Google Scholar
• Ahmed A, Ali SA, Hassan F, Ali SS, Haque N. Dissolution rate studies on acetaminophen tablets. Pak J Pharm Sci 1999;13:39–43
   Google Scholar
• Carstensen JT, Hou XP. The Athy-Heckel equation applied to granular agglomerates of basic tricalcium phosphate [3Ca3PO4)2·Ca(OH)2]. Powder Technol 1985;42:153–157.
   Web of Science ®Google Scholar
• Sonnergaard JM. A critical evaluation of the Heckel equation. Int J Pharm 1999;193:63–71.
   PubMed Web of Science ®Google Scholar
• Baie SB, Newton JM, Podczeck F. The characterization of the mechanical properties of pharmaceutical materials. Eur J Pharm Biopharm 1996;43:138–141.
   Google Scholar
• Kobayashi Y, Ito S, Itai S, Yamamoto K. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int J Pharm 2000;193:137–146.
   PubMed Web of Science ®Google Scholar